Evidence map›Paper›PMID 34335546›Full record

ArticleFrontiers in microbiology2021

Circulating Levels of the Short-Chain Fatty Acid Acetate Mediate the Effect of the Gut Microbiome on Visceral Fat.

Ana Nogal, Panayiotis Louca, Xinyuan Zhang, Philippa M Wells, Claire J Steves, Tim D Spector, Mario Falchi, Ana M Valdes, Cristina Menni

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 1 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 1 synthesis or guideline pooled it, 190 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ana NogalDepartment of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.
Panayiotis LoucaDepartment of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.
Xinyuan ZhangDepartment of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.
Philippa M WellsDepartment of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.
Claire J StevesDepartment of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.
Tim D SpectorDepartment of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.
Mario FalchiDepartment of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.
Ana M ValdesDepartment of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.
Cristina MenniDepartment of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.
King's College London · GB

Funding

Medical Research Council MR/N01183X/1Medical Research Council MR/N030125/1Wellcome Trust
6 · The paper itself

Abstract

backgroundAcetate is a short-chain fatty acid (SCFA) produced by gut bacteria, which has been implicated in cardio-metabolic health. Here we examine the relationships of circulating acetate levels with gut microbiome composition and diversity and with visceral fat in a large population-based cohort.

resultsMicrobiome alpha-diversity was positively correlated with circulating acetate levels (Shannon, Beta [95%CI] = 0.12 [0.06, 0.18],

conclusionsOur data indicates that gut microbiota composition and diversity may influence circulating acetate levels and that acetate might exert benefits on certain cardio-metabolic disease risk by decreasing visceral fat.

Indexed as

acetateCoprococcushuman gut microbiotaLachnoclostridiumvisceral fat

Identifiers

PMID34335546
PMCPMC8320334
OpenAlexW3184669190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.